NURS 6630 Midterm Exam
Question1 1
out of 1 points
When an unstable patient asks why it is necessary to add
medications to his current regimen, the
... [Show More] PMHNP’s best response
would be:
Selected
Answer:
C.
“Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
Question 2
0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin
taking medication again to treat her bipolar depression; she is
breastfeeding her 2-month old daughter. The PMHNP recognizes
that which of the following medications is contraindicated for this
patient?
Selected
Answer:
C.
Lithium
(Lithobid)
Question 3
1 out of 1 points
Mr. Gordon is a middle-aged client who was started on antidepressant
monotherapy for depression. After beginning this medication, the PMHNP
noticed that this client seemed to swing into a hypomanic episode. What can
the PMHNP infer from this behavior change?
Selected
Answer:
A.
This client may have Bipolar III disorder
Question 4
1 out of 1 points
A patient presents with frequent episodes of mania. Which
statement describes an appropriate treatment approach for this
patient?
Selected
Answer:
B.
“The patient could benefit from an
NURS 6630 Midterm Exam Latest 2021, Walden University
anticonvulsant.”
Question 5
1 out of 1 points
The student inquires about antipsychotic medications. Which
response by the PMHNP describes the factors that contribute to
reduced risk of extrapyramidal symptoms (EPS) for patients who
take antipsychotics?
Selected
Answer:
B.
Those that are potent D2 antagonists with 5HT2A
antagonism properties
Question 6
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for
which possible effect?
Selected
Answer:
D.
All of the
above
Question 7
1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics
heard the psychiatrist tell the patient that the patient would be
placed on a different antipsychotic agent called an atypical
antipsychotic. What neurotransmitters will this new medication work on?
Selected
Answer:
A.
dopamine and serotonin
Question 8
1 out of 1 points
While genes have potential to modify behavior, behavior can also
modify genes. How do genes impact this process?
Selected
Answer:
B.
Changes made to proteins lead to changes in
behavior.
Question 9
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no
established history of depression. When meeting with the PMHNP, she
presents with apathy and withdrawn social behavior, and she reports a loss
of joy from enjoyable activities since starting her new medication. What does
the PMHNP infer from this encounter with the client?
Selected
Answer:
C.
The new medication is blocking D2 receptors in the mesolimbic
system
Question 10
1 out of 1 points
A nursing student is seeking clarification on the use of
anticonvulsants to treat depression and is unclear about most
effective outcomes. Which of the following agents does the PMHNP
convey as having uncertain outcomes?
Selected
Answer:
B.
Gabapentin
(Neurontin)
Question 11
1 out of 1 points
As it relates to G-protein linked receptors, what does the PMHNP
understand about medications that are used in practice?
Selected
Answer:
A.
Most medications that act on G-protein linked
receptors have antagonistic traits.
Question 12
1 out of 1 points
A patient is seeking pharmacological treatment for smoking
cessation. Which drug class does the PMHNP prescribe to the
patient?
Selected
Answer:
D.
Varenicline
(Chantix)
Question 13
1 out of 1 points
The PMHNP is caring for a patient with schizophrenia and is
considering a variety of treatment approaches. The PHMNP selects
a viable treatment that is consistent with the “dopamine
hypothesis of schizophrenia.” What action does the PMHNP
anticipate this treatment having on the patient?
Selected
Answer:
B.
Hyperactivity in the mesolimbic dopamine pathway
mediates the positive symptoms of schizophrenia.
Question 14
1 out of 1 points
Though medications have the ability to target neurotransmitter release into
the synapse by the presynaptic neuron it is not always necessary. The PMHNP
understands that this is because:
Selected
Answer:
C.
Neurotransmitters can spread by
diffusion.
Question 15
1 out of 1 points
A patient is being prescribed a sedating antidepressant, but is
concerned about weight gain. Which medication is most likely to be
prescribed to addresses the patient’s concerns?
Selected
Answer:
D.
trazadone
(Oleptro)
Question 16
1 out of 1 points
The PMHNP is caring for several patients who present with various
symptoms and health issues. For which patient does the PMHNP
prescribe pregabalin (Lyrica)?
Selected
Answer:
B.
Patient with partial
seizures
Question 17
1 out of 1 points
Which statement about neurotransmitters and medications is true?
Selected
Answer:
B.
Several psychiatric medications have been developed after discoveries of endogenous
neurotransmitters and defining their function in the brain.
Question 18
1 out of 1 points
A patient is prescribed 50 mg of desvenlafaxine to take every other
day for major depressive disorder. What does the PMHNP
understand about this patient?
Selected
Answer:
C.
The patient has severe renal
impairment.
Question 19
0 out of 1 points
A patient with schizophrenia is given an inverse agonist that acts
on the receptor 5HT and neurotransmitter serotonin. What is the
rationale for prescribing a medication such as this?
Selected
Answer:
A.
To promote the availability of
serotonin
Question 20
1 out of 1 points
A patient who was prescribed an MAO inhibitor is learning about
dietary modifications. Which statement made by the PMHNP
demonstrates proper teaching of the food-drug interactions for
MAO inhibitors?
Selected
Answer:
A.
“You must avoid soy products, such
as tofu.”
Question 21
1 out of 1 points
The PMHNP evaluates the patient for “fear conditioning” when he
asks:
Selected
Answer:
A.
Have you ever experienced any type of
trauma?
Question 22
0 out of 1 points
The PMHNP recognizes that which patient would be contraindicated
for antidepressant monotherapy?
Selected
Answer:
A.
Patient with a bipolar I
designation
Question 23
0 out of 0 points
When completing this exam, did you comply with Walden University’s Code of
Conduct including the expectations for academic integrity?
Selected
Answer:
Ye
s
Question 24
0 out of 1 points
Mr. Gordon is a middle-aged patient who is taking antipsychotics.
When meeting with the PMHNP, he reports positive responses to
the medication, stating, “I really feel as though the effects of my
depression are going away.” Which receptor action in antipsychotic
medications is believed to be the most beneficial in producing the
effects described by Mr. Gordon?
Selected
Answer:
D.
D2 partial
agonist
Question 25
1 out of 1 points
The PMHNP understands that which mechanism contributes to a
worse tolerability profile for patients taking tricyclic
antidepressants (TCAs)?
Selected
Answer:
B.
Muscarinic M1 receptor blockade causes
blurred vision.
Question 26
1 out of 1 points
The PMHNP is assessing a client in the emergency room. The client shares that he
has been on lithium for many years. What blood test does the PMHNP order?
Selected
Answer:
A.
Thyroid Stimulating Hormone
Question 27
1 out of 1 points
A noncompliant patient states, “Why do you want me to put this
poison in my body?” Identify the best response made by the
psychiatric-mental health nurse practitioner (PMHNP). [Show Less]